ロード中...
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Androgen receptor (AR) is an attractive target in breast cancer because of its frequent expression in all the molecular subtypes, especially in estrogen receptor (ER)-positive luminal breast cancers. We have previously shown a role for AR overexpression in tamoxifen resistance. We engineered ER-posi...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4337991/ https://ncbi.nlm.nih.gov/pubmed/25178514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3082-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|